Healthcare providers look to life sciences organizations to support the delivery of benefit coverage information with speed, accuracy and clarity so they can present the best clinical option for their patients with confidence in their understanding of the patient’s out of pocket cost.
Chief Commercial Officer Edward Hensley discusses the differences between various electronic benefit verification methods and how they can impact your program in Drug Channels, one of the industry’s leading publications offering expert insights on pharmaceutical economics and drug distribution systems.